Mumbai, June 11 -- The launch follows the European Commission's marketing authorisation granted to Cassiopea S.p.A., a subsidiary of Cosmo N.V., in October 2025 for use in adults and adolescents aged 12 to under 18 years, with adolescent use limited to facial application.

Glenmark has initiated direct launches in several European markets, including the Nordics, Central and Eastern Europe, and Spain. In Portugal, the product is being introduced through a strategic partner. The company is also advancing additional launches through strategic partnerships across other European markets.

The product is approved in the European Union for the treatment of acne vulgaris in both adults and adolescents. It has been developed by Cassiopea, which ho...